Cargando…
Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions
Opportunistic fungal infections have high mortality in patients with severe immune dysfunction. Growing evidence suggests that the immune environment of invasive fungal infections and cancers share common features of immune cell exhaustion through activation of immune checkpoint pathways. This obser...
Autores principales: | Wurster, Sebastian, Watowich, Stephanie S., Kontoyiannis, Dimitrios P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640966/ https://www.ncbi.nlm.nih.gov/pubmed/36389687 http://dx.doi.org/10.3389/fimmu.2022.1018202 |
Ejemplares similares
-
Autoantibodies in Systemic Sclerosis: Unanswered Questions
por: Kayser, Cristiane, et al.
Publicado: (2015) -
Top five unanswered questions in fungal cell surface research
por: Gow, Neil A.R., et al.
Publicado: (2023) -
Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis
por: Wurster, Sebastian, et al.
Publicado: (2022) -
SARS unanswered questions
por: Zandonella, Catherine
Publicado: (2003) -
Traveling into Outer Space: Unanswered Questions about Fungal Extracellular Vesicles
por: Rodrigues, Marcio L., et al.
Publicado: (2015)